These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19670417)

  • 1. Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.
    Rauch A; James I; Pfafferott K; Nolan D; Klenerman P; Cheng W; Mollison L; McCaughan G; Shackel N; Jeffrey GP; Baker R; Freitas E; Humphreys I; Furrer H; Günthard HF; Hirschel B; Mallal S; John M; Lucas M; Barnes E; Gaudieri S
    Hepatology; 2009 Oct; 50(4):1017-29. PubMed ID: 19670417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.
    Gaudieri S; Rauch A; Park LP; Freitas E; Herrmann S; Jeffrey G; Cheng W; Pfafferott K; Naidoo K; Chapman R; Battegay M; Weber R; Telenti A; Furrer H; James I; Lucas M; Mallal SA
    J Virol; 2006 Nov; 80(22):11094-104. PubMed ID: 17071929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak.
    Merani S; Petrovic D; James I; Chopra A; Cooper D; Freitas E; Rauch A; di Iulio J; John M; Lucas M; Fitzmaurice K; McKiernan S; Norris S; Kelleher D; Klenerman P; Gaudieri S
    Hepatology; 2011 Feb; 53(2):396-405. PubMed ID: 21246583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.
    Gaudieri S; Rauch A; Pfafferott K; Barnes E; Cheng W; McCaughan G; Shackel N; Jeffrey GP; Mollison L; Baker R; Furrer H; Günthard HF; Freitas E; Humphreys I; Klenerman P; Mallal S; James I; Roberts S; Nolan D; Lucas M
    Hepatology; 2009 Apr; 49(4):1069-82. PubMed ID: 19263475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of CD4
    Lucas M; Deshpande P; James I; Rauch A; Pfafferott K; Gaylard E; Merani S; Plauzolles A; Lucas A; McDonnell W; Kalams S; Pilkinton M; Chastain C; Barnett L; Prosser A; Mallal S; Fitzmaurice K; Drummer H; Ansari MA; Pedergnana V; Barnes E; John M; Kelleher D; Klenerman P; Gaudieri S
    Sci Rep; 2018 May; 8(1):7224. PubMed ID: 29740042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection.
    Lange CM; Roomp K; Dragan A; Nattermann J; Michalk M; Spengler U; Weich V; Lengauer T; Zeuzem S; Berg T; Sarrazin C
    J Hepatol; 2010 Dec; 53(6):1022-8. PubMed ID: 20800922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.
    Pfafferott K; Deshpande P; McKinnon E; Merani S; Lucas A; Heckerman D; Mallal S; John M; Gaudieri S; Lucas M
    PLoS One; 2015; 10(6):e0130420. PubMed ID: 26107956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.
    Prabdial-Sing N; Puren AJ; Bowyer SM
    BMC Immunol; 2012 Dec; 13():67. PubMed ID: 23227878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity.
    Pfafferott K; Gaudieri S; Ulsenheimer A; James I; Heeg M; Nolan D; John M; Rauch A; Mallal S; Lucas A; Klenerman P; Diepolder HM; Lucas M
    PLoS One; 2011 Feb; 6(2):e16797. PubMed ID: 21347433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.
    Timm J; Li B; Daniels MG; Bhattacharya T; Reyor LL; Allgaier R; Kuntzen T; Fischer W; Nolan BE; Duncan J; Schulze zur Wiesch J; Kim AY; Frahm N; Brander C; Chung RT; Lauer GM; Korber BT; Allen TM
    Hepatology; 2007 Aug; 46(2):339-49. PubMed ID: 17559151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of T-cell epitopes of hepatitis C virus genotype 5a.
    Gededzha MP; Mphahlele MJ; Selabe SG
    Virol J; 2014 Nov; 11():187. PubMed ID: 25380768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.
    Kim AY; Kuntzen T; Timm J; Nolan BE; Baca MA; Reyor LL; Berical AC; Feller AJ; Johnson KL; Schulze zur Wiesch J; Robbins GK; Chung RT; Walker BD; Carrington M; Allen TM; Lauer GM
    Gastroenterology; 2011 Feb; 140(2):686-696.e1. PubMed ID: 20875418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Transmitted Virus on the Host's Immune Response: A Case Study.
    Merani S; Lucas M; Deshpande P; Pfafferott K; Chopra A; Cooper D; Leary S; Luciani F; Gaudieri S
    Viral Immunol; 2017 Sep; 30(7):533-541. PubMed ID: 28530508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level.
    Neumann-Haefelin C; Frick DN; Wang JJ; Pybus OG; Salloum S; Narula GS; Eckart A; Biezynski A; Eiermann T; Klenerman P; Viazov S; Roggendorf M; Thimme R; Reiser M; Timm J
    J Virol; 2008 Apr; 82(7):3438-51. PubMed ID: 18216107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.
    Neumann-Haefelin C; Timm J; Schmidt J; Kersting N; Fitzmaurice K; Oniangue-Ndza C; Kemper MN; Humphreys I; McKiernan S; Kelleher D; Lohmann V; Bowness P; Huzly D; Rosen HR; Kim AY; Lauer GM; Allen TM; Barnes E; Roggendorf M; Blum HE; Thimme R
    Hepatology; 2010 Jan; 51(1):54-62. PubMed ID: 20034048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential escape of HCV from CD8
    Xia Y; Pan W; Ke X; Skibbe K; Walker A; Hoffmann D; Lu Y; Yang X; Feng X; Tong Q; Timm J; Yang D
    J Viral Hepat; 2019 Jan; 26(1):73-82. PubMed ID: 30260541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.
    Desmond CP; Gaudieri S; James IR; Pfafferott K; Chopra A; Lau GK; Audsley J; Day C; Chivers S; Gordon A; Revill PA; Bowden S; Ayres A; Desmond PV; Thompson AJ; Roberts SK; Locarnini SA; Mallal SA; Lewin SR
    J Virol; 2012 Jan; 86(2):1181-92. PubMed ID: 22072755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.